Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

391 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
Ratjen F, Döring G, Nikolaizik WH. Ratjen F, et al. Lancet. 2001 Sep 22;358(9286):983-4. doi: 10.1016/S0140-6736(01)06124-4. Lancet. 2001. PMID: 11583754
Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis.
Grasemann H, Michler E, Wallot M, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Pediatr Pulmonol. 1997 Sep;24(3):173-7. doi: 10.1002/(sici)1099-0496(199709)24:3<173::aid-ppul2>;2-o. Pediatr Pulmonol. 1997. PMID: 9330413
Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
Wiesemann HG, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, Döring G, von der Hardt H. Wiesemann HG, et al. Among authors: ratjen f. Pediatr Pulmonol. 1998 Feb;25(2):88-92. doi: 10.1002/(sici)1099-0496(199802)25:2<88::aid-ppul3>;2-j. Pediatr Pulmonol. 1998. PMID: 9516091 Clinical Trial.
Nitric oxide metabolites in cystic fibrosis lung disease.
Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Arch Dis Child. 1998 Jan;78(1):49-53. doi: 10.1136/adc.78.1.49. Arch Dis Child. 1998. PMID: 9534676 Free PMC article.
Comparison of the in vitro and in vivo response to inhaled DNase in patients with cystic fibrosis.
Ratjen F, Tummler B. Ratjen F, et al. Thorax. 1999 Jan;54(1):91. doi: 10.1136/thx.54.1.91. Thorax. 1999. PMID: 10343641 Free PMC article. No abstract available.
Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis.
Ratjen F, Gärtig S, Wiesemann HG, Grasemann H. Ratjen F, et al. Respir Med. 1999 Aug;93(8):579-83. doi: 10.1016/s0954-6111(99)90158-0. Respir Med. 1999. PMID: 10542992
Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome.
Grasemann H, Gärtig SS, Wiesemann HG, Teschler H, Konietzko N, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Eur Respir J. 1999 Jan;13(1):114-8. doi: 10.1183/09031936.99.13111499. Eur Respir J. 1999. PMID: 10836334
Changes in strategies for optimal antibacterial therapy in cystic fibrosis.
Ratjen F. Ratjen F. Int J Antimicrob Agents. 2001 Feb;17(2):93-6. doi: 10.1016/s0924-8579(00)00333-2. Int J Antimicrob Agents. 2001. PMID: 11165111 Review.
Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis.
Ratjen F, Comes G, Paul K, Posselt HG, Wagner TO, Harms K; German Board of the European Registry for Cystic Fibrosis (ERCF). Ratjen F, et al. Pediatr Pulmonol. 2001 Jan;31(1):13-6. doi: 10.1002/1099-0496(200101)31:1<13::aid-ppul1001>;2-n. Pediatr Pulmonol. 2001. PMID: 11180669
Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.
Bald M, Ratjen F, Nikolaizik W, Wingen AM. Bald M, et al. Among authors: ratjen f. Pediatr Infect Dis J. 2001 Mar;20(3):320-1. doi: 10.1097/00006454-200103000-00024. Pediatr Infect Dis J. 2001. PMID: 11303842
391 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page